Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Cash-Producing Stocks Walking a Fine Line

By: StockStory

April 24, 2026 at 00:33 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

FORM Cover Image

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Luckily for you, we built StockStory to help you separate the good from the bad. Keeping that in mind, here are three cash-producing companies to avoid and some better opportunities instead.

FormFactor (FORM)

Trailing 12-Month Free Cash Flow Margin: 1.5%

With customers across the foundry and fabless markets, FormFactor (NASDAQ: FORM) is a US-based provider of test and measurement technologies for semiconductors.

Why Does FORM Give Us Pause?

Sales trends were unexciting over the last five years as its 2.5% annual growth was below the typical semiconductor company
Gross margin of 39.8% reflects its high production costs
Low free cash flow margin of 5.9% declined over the last five years as its investments ramped, giving it little breathing room

At $150.00 per share, FormFactor trades at 78.9x forward P/E. Dive into our free research report to see why there are better opportunities than FORM.

The Honest Company (HNST)

Trailing 12-Month Free Cash Flow Margin: 3.7%

Co-founded by actress Jessica Alba, The Honest Company (NASDAQ: HNST) sells diapers and wipes, skin care products, and household cleaning products.

Why Is HNST Risky?

Sales trends were unexciting over the last three years as its 5.8% annual growth was below the typical consumer staples company
Subscale operations are evident in its revenue base of $371.3 million, meaning it has fewer distribution channels than its larger rivals
Push for growth has led to negative returns on capital, signaling value destruction

The Honest Company is trading at $3.41 per share, or 37.8x forward P/E. To fully understand why you should be careful with HNST, check out our full research report (it’s free).

U.S. Physical Therapy (USPH)

Trailing 12-Month Free Cash Flow Margin: 7.8%

With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE: USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.

Why Are We Cautious About USPH?

Smaller revenue base of $781 million means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
Incremental sales over the last five years were less profitable as its 1.9% annual earnings per share growth lagged its revenue gains
Free cash flow margin dropped by 6 percentage points over the last five years, implying the company became more capital intensive as competition picked up

U.S. Physical Therapy’s stock price of $74.84 implies a valuation ratio of 26.2x forward P/E. If you’re considering USPH for your portfolio, see our FREE research report to learn more.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	241.26	-4.72 (-1.92%)
AAPL	310.04	-0.62 (-0.20%)
AMD	504.06	-12.05 (-2.33%)
BAC	58.54	-1.32 (-2.21%)
GOOG	358.22	-5.40 (-1.48%)
META	603.65	-11.93 (-1.94%)
MSFT	382.31	-6.53 (-1.68%)
NVDA	197.37	+0.44 (0.22%)
ORCL	138.13	-3.47 (-2.45%)
TSLA	392.35	-10.55 (-2.62%)